Society for Endocrinology - a world-leading authority on hormones

Events

Webinar Topics

Clinical Skills Webinars will be taking place monthly, available free to Society members who register and attend the live Webinar, or by streaming the session on demand in the Members' Area.

If you are not a member of the Society and wish to access the webinar series, you can apply for membership by visiting the membership page.

For information on how to access the webinars please visit the registration page.

Upcoming Webinars:

Speakers: Dr Abd Tahrani (Birmingham), Mary O’Kane (Leeds), Dr Stephanie de Georgio (Kent) and Dr Barbara McGowan (Kings College London)

 

Dr Barbara McGowan is a Consultant Endocrinologist at Guy's and St Thomas' Hospital and Honorary Professor in Diabetes and Endocrinology at King’s College London.  She was awarded a PhD from Imperial College London for investigating ‘The role of relaxin-3 on energy homeostasis and the hypothalamic-pituitary axis and the role of gut hormones and other neuropeptides in appetite control.

She is the R&D lead for Diabetes and Endocrinology at GSTT and the South London Specialty lead for the Metabolic and Endocrine research network. She leads the obesity bariatric service at Guy's and St Thomas' Hospital where she manages patients with complex obesity. Her areas of research interest are in gut hormones and appetite control, pharmacotherapy for obesity and remission of type 2 diabetes post-bariatric surgery. She is an investigator for several obesity clinical trials and was awarded an NIHR/RCP/CRN prize in recognition of outstanding research within the NHS.

Dr McGowan was a Trustee of The Association for the Study of Obesity, is a member of the ASO obesity management sub-committee and a SCOPE National fellow. She was the Treasurer for the UK Society of Endocrinology and is a member of the RCP Advisory Group on Weight and Health.

Mary O’Kane is an Honorary Consultant Dietitian (Adult Obesity) at Leeds Teaching Hospitals NHS Trust. She has extensive experience of specialist weight management and surgical obesity clinics.

Mary has served on several national committees including NICE Clinical Guidelines Obesity (2006 and 2014) and the British Obesity and Metabolic Surgery Society (BOMSS). She sits on the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) IFSO Executive Board and chairs the IFSO Integrated Health Committee. Mary is a Co-opted Trustee for the Association for the Study of Obesity UK and co-opted member of its Clinical Practice and Obesity Management Sub-Committee. She is a committee member of the British Dietetic Association Obesity Specialist Group.

Mary led the development of the first BOMSS nutritional guidelines in 2014 and it update published in 2020. She was presented with the BDA Elizabeth Washington Award for the development of long-term follow for people undergoing bariatric surgery, published in 2016.

Mary was awarded Fellow of the British Dietetic Association for her contribution to national work and advancement of dietetic practice.

Abd Tahrani is a Senior Lecturer in Metabolic Endocrinology and Obesity Medicine at the University of Birmingham (UoB). Abd is also an Honorary Consultant in Endocrinology, Diabetes & Weight Management, and the lead for weight management research and diabetic neuropathy services at the University Hospitals Birmingham NHS Foundation Trust. He is the lead for translational research in the Centre of Endocrinology, Diabetes and Metabolism (CEDAM), Birmingham Health Partners.
Abd received several awards including NIHR research training fellowship (2008), NIHR Clinician Scientist (2012), the American Academy of Sleep Medicine Young Investigator award in OSA research (2013), and SCOPE National & International Fellowships from the World Obesity Federation in (2014 & 2020). Abd’s research themes are 1) the metabolic consequences of sleep-related disorders, 2) obesity management & health care delivery, 3) diabetes-related neuropathy.
Abd has published over 160 peer-reviewed articles and delivered more than 100 invited talks in the leading conferences globally. Abd is a trustee of ASO (UK) and a panel member of the British Sleep Society Research Committee. Abd is also and an Expert Advisor to NICE and a member of the strategic council of the Obesity All-Party Parliamentary Group (Obesity APPG). He is the Chair of the Clinical Practice and Obesity Management Committee of ASO (UK) and a member of the Obesity Policy Engagement Network (OPEN) UK. He is a regular peer reviewer to the leading journals and research funding organisations. Abd is an associate editor for the European Journal of Endocrinology and the Diabetes Section Editor for BMC Endocrine Disorders.

 

Dr Stephanie de Giorgio is a GP in East Kent who has a professional interest in the management of obesity and overweight. She has written the RCGP e-learning modules on obesity and overweight in adults and adolescents and teaches GPs nationwide about the science of obesity as well as the management of Obesity and overweight in primary care. 

Having a person living with obesity, who had bariatric surgery, she is very aware of the effects of weight stigma on individuals and has worked within commissioning organisations and seen the effects of systemic weight stigma on service design as well as problems at practice level. She works with obesity organisations to try to educate regarding the damaging effects weight stigma has

Speaker: Ms Maria Piggin (London

Host: Dr Ali Abbara (London)

Session Overview:

The involvement of patients and the public in the design and conduct of research is essential in ensuring that research is high quality and relevant to patients. This session will explain the difference between public involvement, public engagement and co-production and give examples of how to involve patients and the public in research in a meaningful way throughout the research cycle. It will also outline some practical considerations for public involvement such as who to involve, how to recruit them and how to reimburse patients and the public appropriately such that they are not disadvantaged by being involved in the research. Relevant resources will be signposted to ensure that attendees are able to conduct high-quality public involvement in preparation for funding applications and throughout research projects.

Dr Ali Abbara is an NIHR Clinician Scientist / Clinical Senior Lecturer / Honorary Consultant in Endocrinology at Imperial College London. He graduated with honours from St Bartholomews’ and the Royal London medical school in 2004. Following an NIHR Academic Clinical Fellowship, he completed a PhD in Reproductive Neuroendocrinology in 2014 supported by a ‘Wellcome Trust Clinical Training Fellowship’. After an NIHR Academic Clinical Lectureship, he received an ‘Imperial Post-doctoral Post-CCT Researcher Fellowship’ and later an ‘NIHR Clinician Scientist Award’ to continue researching clinical applications of hypothalamic neuropeptides. In 2019, he received a ‘Society for Endocrinology Leadership and Development Award’.

Maria Piggin, Partnerships and Training Manager, Imperial Patient Experience Research Centre, Imperial College, London

Maria is the Partnerships and Training Manager within the Patient Experience Research Centre (PERC) sitting within the School of Public Health at Imperial College, London. Her role includes delivering public involvement training and provides public involvement advice and support to the NIHR Imperial Biomedical Research Centre. She is also the PPIE co-lead of the Health Protection Research Unit (HPRU) in Modelling and Health Economics. Maria also established, and is the Chair of, a national support charity for patients with an ultra-rare disease. In this role she engages with patients as well as various stakeholders (on behalf of patients) including NHS England, pharmaceutical companies, NICE and the NHS.


Webinars that are now available to stream within the Members' Area 

Dr Miles Levy (Leicester) & Professor Mark Sherlock (Dublin, Ireland)

Session overview:

  • Introduction & What’s new in D.I?
  • Pitfalls in diagnosis of D.I
  • Nuances of DI Management
  • How to approach Adipsic DI
  • Acute aspects of DI Management

Stream-on-demand the first webinar within the Members' Area.

Speaker biography:

Dr Miles  Levy, Consultant Endocrinologist, University Hospitals of Leicester. Dr Levy was appointed Consultant Endocrinologist at University Hospitals of Leicester in 2005 and is currently an Honorary Associate Professor at Leicester University. Dr Levy's research interests include the genetics of endocrine tumours, functional imaging in endocrine tumours and the association of pituitary tumours and headache. Miles is the CRG Lead Endocrinology for Midlands and East, and Training Programme Director for Diabetes and Endocrinology East Midlands South. Dr Levy has an active role within the Society is currently a member of both the Clinical Committee and Public Engagement Committee, a Media Advisor for the Society and he is also Editor in Chief for You and Your Hormones, the Society’s public-facing website. He co-writes the endocrinology chapter for Kumar & Clarke and Endocrinology at a Glance and is the education Lead for Endocrinology at Leicester Medical School.

Professor Mark Sherlock graduated from the Royal College of Surgeons in Ireland in 2000. He received his specialist endocrine training initially in Beaumont Hospital.  Following this, he received specialist training in Endocrinology in the Queen Elizabeth Hospital, Birmingham and the University of Birmingham, where he spent five years. He received his MD thesis for studies related to morbidity and mortality in patients with acromegaly. He obtained his PhD thesis from the University of Birmingham for studies relating to cortisol metabolism in muscle and in patients receiving hydrocortisone therapy. Professor Sherlock’s main clinical and research interests are in all areas of pituitary and adrenal disease and salt and water homeostasis.

 

Dr John Ayuk (Birmingham), Professor William Drake (London) & Professor Mark Sherlock (Dublin, Ireland)

Session 1 with Professor Mark Sherlock: Morbidity and mortality in acromegaly

Session 2 with Professor William Drake: Acromegaly; large difficult tumours

Session 3 with Dr John Ayuk: Radiotherapy in the management of acromegaly - the good, the bad, and the not so ugly?

Stream-on-demand the second webinar within the Members' Area.

John Ayuk is a Consultant Endocrinologist at University Hospitals Birmingham. He trained in Endocrinology in the West Midlands, completing a Research Fellowship in Endocrinology and being awarded an MD at the University of Birmingham. His clinical and research interests include the pathogenesis, management and outcome of endocrine tumours. He is the author of a number of papers that have influenced changes in the way pituitary disease is managed, and as a result, is regularly involved in writing consensus guidelines. He also holds the post of Honorary Senior Lecturer at the University of Birmingham and is the Chair of the UK Acromegaly Register Steering Committee. 

Professor Drake trained at the University of Oxford and the Royal London Hospital Medical College. After junior medical jobs in London and in Cape Town, South Africa, he returned to the UK to specialise in Endocrinology at St Bartholomew’s Hospital. Following a 12 month medicine and endocrinology fellowship in Vancouver, Canada, he returned to the UK and is now a Consultant Physician/Professor of Clinical Endocrinology at St Bartholomew’s Hospital.

Professor Mark Sherlock graduated from the Royal College of Surgeons in Ireland in 2000. He received his specialist endocrine training initially in Beaumont Hospital. Following this, he received specialist training in Endocrinology in the Queen Elizabeth Hospital, Birmingham and the University of Birmingham, where he spent five years. He received his MD thesis for studies related to morbidity and mortality in patients with acromegaly.  He obtained his PhD thesis from the University of Birmingham for studies relating to cortisol metabolism in muscle and in patients receiving hydrocortisone therapy. Professor Sherlock’s main clinical and research interests are in all areas of pituitary and adrenal disease and salt and water homeostasis.

Dr Niki Karavitaki (Birmingham) & Dr Robert Murray (Leeds).

Session 1: Prolactinoma Background

Session 2: Prolactinoma – Dopamine Agonist Withdrawal

Session 3: Giant Prolactinomas

Session 4: Prolactinoma – Dopamine Agonist Adverse Effects

Session 5: Dopamine Agonist Resistance

Stream-on-demand the third webinar within the Members' Area.

Dr Niki Karavitaki, MSc, PhD, FRCP Senior Clinical Lecturer in Endocrinology and Honorary Consultant Endocrinologist. Institute of Metabolism and Systems Research (IMSR), College of Medical and Dental Sciences, University of Birmingham; Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust; Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, UK

Niki Karavitaki is Senior Clinical Lecturer (University of Birmingham) and Honorary Consultant Endocrinologist (University Hospitals Birmingham NHS Foundation Trust). She leads the academic Pituitary Theme at the Institute of Metabolism and Systems Research (University of Birmingham) and she is the co-lead of the Pituitary Service at the Queen Elizabeth Hospital Birmingham.

Her clinical and research interests focus on pituitary tumours and hypopituitarism and she has published extensively on the field. She has active involvement in national and international committees and she was the Chair of the Programme Organising Committee of the European Neuroendocrine Association 2020 Congress. 

Dr Robert Murray is a Consultant Endocrinologist & Honorary Associate Professor at Leeds Teaching Hospitals NHS Trust, having been appointed in 2004. His subspecialty interests, both clinically and research, lie in pituitary disease, late-endocrine effects of cancer, and optimising hormone replacement therapies.

Dr Murray is active in producing research data to improve our knowledge and treatment of patients with pituitary disease. Dr Murray is an active member of the Society for Endocrinology (SfE) Clinical Committee (2010-13 & 2018-date), Public Engagement Committee (2018-date) and medical board of the Pituitary Foundation. He has previously served on the RCP Joint Specialty Committee for Diabetes and Endocrinology (2005-10), SfE Nurses Committee (2010-13), and SfE Corporate Liasion Committee (2010-13). Dr Murray is on the Editorial boards of the journals ‘Pituitary’, ‘Diabetes, Endocrinology & Metabolism’ and ‘Advances in Therapy’. Locally Dr Murray has been very involved with education serving as TPD for West Yorkshire Diabetes & Endocrinology specialist training (2015-19).

Professor Simon Pearce (Newcastle-upon-Tyne) & Professor Kristien Boelaert (Birmingham)

Session 1 – Evaluation of Thyroid Nodules
Session 2 – Evaluation of Thyroid Nodules
Session 3 – Management of Thyroid Cancer
Session 4 – Management of Thyroid Cancer

Stream-on-demand the fourth webinar within the Members' Area.

Kristien Boelaert is a Professor of Endocrinology at the University of Birmingham and a Consultant Endocrinologist at University Hospitals Birmingham. Her clinical research interests include the management of thyroid dysfunction, nodules and cancer as well as endocrine disorders in pregnancy. Her laboratory research programme focuses on the pathogenesis of thyroid cancer and she is involved in a number of clinical trials in the field of thyroid diseases. She was the Clinical Lead for the NICE Guidelines on Thyroid Diseases and leads the National Consensus Statements on Management of Thyroid Cancer and the RCOG Green-Top guideline on Thyroid Diseases in Pregnancy. She has drafted guidance for the SfE and the ESE on management of thyroid dysfunction during COVID-19. Kristien’s research continues to attract funding from major grant awarding bodies and she has a rapidly growing list of publication (h-index = 42) and numerous invitations to speak at international conferences. She is Senior Editor for Endocrine Connections and BMC Endocrine Disorders and serves on the Editorial Boards of several endocrine journals including Lancet Diabetes & Endocrinology. She is a member of the Society for Endocrinology Council and Clinical Committee, The ATA Awards Committee, the Endocrine Society Annual Steering Meeting Committee and the RCP Specialist Certificate Examination Board.

Simon Pearce is a Professor of Endocrinology at Newcastle University since 2007, and an Honorary Consultant Physician at Newcastle’s Royal Victoria Infirmary. He trained in Newcastle, London and Boston. He is past Programme Secretary for the Society for Endocrinology (2016-2018), Editor in Chief of European Thyroid Journal and current President of the British Thyroid Association. The focus of his research programme is to improve the management of autoimmune thyroid and adrenal conditions. He has published more than 180 research papers.

Host: Dr Ruth Casey (Cambridge)

Speakers: Dr Michael O'Reilly (Dublin, Ireland) & Professor Mark Gurnell (Cambridge)

Stream-on-demand the fifth webinar within the Members' Area.

Session overview:

Session 1: States of mineralocorticoid excess

Session 2: Pathophysiology and genetics

Session 3: Diagnostics

Session 4: Treatment.

 

Dr Micheal O’Reilly is a Consultant Endocrinologist in Beaumont Hospital, Dublin, and Clinical Associate Professor at the Royal College of Surgeons in Ireland (RCSI). He is an honours graduate of the National University of Ireland Galway (NUIG, 2005). His Clinical PhD fellowship into androgen metabolism was funded by the Wellcome Trust from 2012 to 2015 at the University of Birmingham. Upon completion of his PhD and clinical specialist training, he was appointed as a Clinician Scientist at the University of Birmingham and Honorary Consultant Endocrinologist, University Hospital Birmingham, from 2015-2019.  He led the Adrenal MDT and established a nurse-led Andrology service at the hospital. Dr O'Reilly is the recipient of numerous national and international awards for his research and is regularly invited to speak on adrenal disease, reproductive endocrinology and androgen excess. Dr O’Reilly returned to a consultant post in Beaumont Hospital Dublin in 2019, and in 2020 received a prestigious Emerging Clinician Scientist Fellowship from the Health Research Board, funding his research into the role of adrenal androgens in health complications in women.

 

Mark Gurnell is Professor of Clinical Endocrinology in Cambridge, where he is Clinical Lead for Endocrine Services. Professor Gurnell is a SubDean in the University of Cambridge School of Clinical Medicine and Head of Undergraduate Assessment. His clinical and research interests are focussed on the pituitary, adrenal and thyroid disorders, with particular interests in:

  • acromegaly
  • Cushing’s disease
  • TSH-secreting pituitary adenomas
  • secondary adrenal insufficiency
  • primary aldosteronism

He is head of the Cambridge Endocrine Molecular Imaging Group (CEMIG) and has led the development of novel PET tracers for imaging pituitary adenomas and adrenocortical tumours, with several now in use in routine clinical practice. He is recognised as an expert in the management of patients with unusual thyroid function tests. He currently serves on various expert committees/panels, including:

  • Council of the UK Society for Endocrinology (Treasurer)
  • Education Committee of the European Society of Endocrinology
  • US Endocrine Society’s ESAP panel
  • Royal College of Physicians (UK) Specialty Certificate Examinations Board (Endocrinology & Diabetes)

He holds a number of senior appointments in medical education and chairs the Board of the UK Medical Schools Council Assessment Alliance. He leads the team of UK Assessment experts developing the forthcoming UK Medical Licensing Assessment (MLA) Applied Knowledge Test (AKT).

Dr Ruth Casey is a consultant endocrinologist in Cambridge University Hospital NHS Foundation Trust and holds an academic position as a senior research fellow in the Department of Medical Genetics at Cambridge University. Dr Casey leads neuroendocrine tumour (NET) and endocrine cancer services in Cambridge and is the endocrine lead for the endocrine genetics service, encompassing both clinical practice and independently-funded research in GIST, phaeochromocytoma and paraganglioma.

Speakers: Dr Richard Quinton (Newcastle-upon-Tyne) and Dr Channa Jayasena (London)

Host: Dr Justyna Witczak (Cardiff)

SESSION OVERVIEW:

Session 1 – Introduction to the topic

Session 2 – Testosterone therapy in men

Session 3 – Sex hormone replacement in females

Session 4 – Gynaecomastia

Stream-on-demand the sixth webinar within the Members' Area.

Host, Dr Justyna Witczak works as a Consultant in Diabetes, Endocrinology and Acute Medicine at the University Hospital of Wales in Cardiff.  Apart from providing specialist care to patients with diabetes and endocrine conditions, she is also involved in research and teaching activities.  

She is a committee member of the Young Diabetologist and Endocrinologist Forum Wales and was elected as the South Wales Representative at the New Consultants’ Committee at the Royal College of Physicians. She is the recipient of the SfE Leadership and Development Clinician in Practice Award  2020. Dr Witczak was previously awarded the Lewis Thomas Gibbon Jenkins Fellowship by RCP Wales to complete research on circulating extracellular vesicles in obesity.

Her clinical and research interests include thyroid disease, obesity, diabetes mellitus type 2 and pituitary disease.

 

Speaker, Dr Channa Jayasena is a Reader and Consultant in Reproductive Endocrinology and Andrology at Imperial College and Hammersmith Hospital, London. Dr Jayasena qualified in medicine at Cambridge University, after which he undertook specialist training in Endocrinology and Diabetes in London. He performed research at Imperial College as a Wellcome Trust Clinical Research Training Fellow and subsequently NIHR Clinical Lecturer. Dr Jayasena has national expertise in the treatment of reproductive disorders. He is currently Clinical Lead for Male Infertility / Andrology at Hammersmith Hospital.

Speaker, Dr Richard Quinton has been a Consultant Endocrinologist at the Royal Victoria Infirmary and Senior Lecturer at Newcastle University since 1999. Dr Quinton graduated from Cambridge University in 1988. Whilst following core medical training at St Bartholomew’s Hospital London and Erasmus University Hospital Rotterdam he gained his CCST. He has published nearly 200 articles, including several in NEJM, JCI, PNAS & BMJ. As well as collaborating with molecular geneticists to identify key genes involved in the neuroendocrine control of human reproduction, his emphasis on careful patient phenotyping and longitudinal follow-up has resulted in novel clinical observations that have changed perceptions of the plasticity of the human GnRH pulse-generator and its resilience in the face of both genetic and environmental insults.
He has long been an active supporter of patient involvement and self-help groups, including those for Kallmann, Klinefelter and Turner syndromes, and was a founder member (currently Vice Chair) of the “GNRH Network” of clinicians, researchers, educators and patients, funded by the EU as part of its Cooperation in Science & Technology programme, which re-shaped directions of travel for collaborative research, patient education and patient access to best care across Europe in the field of central hypogonadotrophic hypogonadism.

Speaker: Dr Rachel Crowley (Dublin, Ireland)

Host: Dr Aoife Garrahy (Dublin, Ireland)

Session Overview

This session will provide a clinical perspective on hypercalcaemia and primary hyperparathyroidism; it will be case-based and the presenters who have delivered this session in the past will build on the usual questions arising, to keep the session informative and interactive.

  • The rush to treat hypercalcaemia with bisphosphonates
  • The exclusion of FHH (and the significance if found)
  • The consideration and benefit assessment of surgery / medical management PHPT
  • Non PHPT causes

Rachel is a clinical endocrinologist at St Vincent’s University Hospital Dublin and is an Associate Clinical Professor at the University College Dublin. Her clinical and research interests are in particularly rare bone, electrolytes, adrenal and pituitary diseases. She runs a national referral clinic for complex bone diseases including XLH and OI, Dr Crowley is an investigator for a number of trials and studies in these cohorts. She is actively involved in clinical research governance in SVUH and Ireland and is also a Patient and Public Involvement clinical champion for UCD. She has been involved with SfE Clinical Update since her first attendance as a trainee in 2014. 

Session Overview

Case presentation 1- TFT changes and hypothyroidism in pregnancy
Case presentation 2 - mild thyroid hypofunction and thyroid autoimmunity in pregnancy
Case presentation 3 - hyperthyroidism in pregnancy
Case presentation 4 - Thyroid nodules and thyroid cancer in pregnancy

Speakers: Professor Bijay Vaidya (Exeter), Professor Kristien Boelaert (Birmingham) and Dr Catherine Napier (Newcastle)

Professor Bijay Vaidya is a Consultant Endocrinologist at the Royal Devon & Exeter Hospital, and an Honorary Clinical Professor at the University of Exeter Medical School in Exeter. He has longstanding clinical and research interest in thyroid diseases, particularly thyroid disorders in pregnancy, and co-authored over 130 papers in peer-reviewed journals. He has served as treasurer and an executive committee member of the British Thyroid Association, a member of the Society for Endocrinology (SfE) clinical committee and a convenor for the SfE Clinical Update (thyroid strand). He is current Secretary of the British Thyroid Association, a member of the SfE programme committee and an executive committee member of the European Thyroid Association. He is joint editor-in-chief of the journal, Thyroid Research

Professor Kristien Boelaert is a Professor of Endocrinology at the University of Birmingham and a Consultant Endocrinologist at University Hospitals Birmingham. Her clinical research interests include the management of thyroid dysfunction, nodules and cancer as well as endocrine disorders in pregnancy. Her laboratory research programme focuses on the pathogenesis of thyroid cancer and she is involved in a number of clinical trials in the field of thyroid diseases. She was the Clinical Lead for the NICE Guidelines on Thyroid Diseases and leads the National Consensus Statements on Management of Thyroid Cancer and the RCOG Green-Top guideline on Thyroid Diseases in Pregnancy. She has drafted guidance for the SfE and the ESE on management of thyroid dysfunction during COVID-19. Kristien’s research continues to attract funding from major grant awarding bodies and she has a rapidly growing list of publication (h-index = 42) and numerous invitations to speak at international conferences. She is Senior Editor for Endocrine Connections and BMC Endocrine Disorders and serves on the Editorial Boards of several endocrine journals including Lancet Diabetes & Endocrinology. She is a member of the Society for Endocrinology Council and Clinical Committee, The ATA Awards Committee, the Endocrine Society Annual Steering Meeting Committee and the RCP Specialist Certificate Examination Board.

Dr Catherine Napier is a Consultant in Endocrinology and Diabetes at the Newcastle upon Tyne Hospitals. Her clinical interests include autoimmune Addison’s disease, endocrine conditions in pregnancy and thyroid eye disease. She has a PhD in autoimmune adrenal and thyroid disease and is an Associate Clinical Lecturer at Newcastle University. She has ongoing clinical research interests in Addison’s disease and thyroid eye disease and is lead for training in Endocrinology and Diabetes in Newcastle upon Tyne. Catherine holds an inaugural Leadership and Development Award from the Society for Endocrinology (2019 -2022). She leads the Obstetric Endocrinology service in the North East and has developed a regional lactation induction service with the Specialist Infant Feeding team to support women with premature ovarian failure, surrogate mothers and same-sex couples.

Speakers: Professor Maralyn Druce (Barts and The London School of Medicine) and Dr Helen Simpson (UCLH, London)

 

Professor Maralyn Druce undertook undergraduate training at Christ's College, Cambridge University and completed her clinical training at University College and Middlesex School of Medicine in 1994. She completed her higher medical training in Diabetes, Endocrinology and General Internal Medicine at the Hammersmith Hospital and Barts Hospital. She was awarded a Wellcome Trust clinical research training fellowship and obtained a PhD in physiology in Professor Steve Bloom's laboratory in Imperial College, focusing on gut hormones and their role in the peripheral and central control of energy homeostasis. Maralyn went on to be awarded the Chadburn Lectureship at Barts and the London School of Medicine and has remained here since then. She has a keen interest in teaching and completed her Masters in Medical Education (Dundee) in 2016. She is now Professor of Endocrine Medicine and Consultant Physician and Endocrinologist at Barts Health NHS Trust.
Current QMUL roles include Deputy Dean for Education (Postgraduate Taught Programmes) and Head of Governance for the Undergraduate MBBS and Dental programmes at Barts and the London. She is also Associate Dean for Undergraduates at the St Bartholomew’s Hospital site.
She has held a number of external roles including Chair of the Society for Endocrinology Public Engagement Committee, Chair of the Education and Training Committee for UKINETs, member of the exam board for the Royal College of Physicians Diabetes and Endocrinology exam and Editor in Chief of Endocrinology, Diabetes and Metabolism Case Reports. She is currently one of the Senior Editors of Clinical Endocrinology.

Dr Helen Simpson is a Consultant Endocrinologist working at UCLH. She was a Consultant at Addenbrooke's Hospital, Cambridge for 12 years and has been at UCLH since 2017. She has a broad clinical experience within endocrinology in the out patient and in patient settings. Whilst at Cambridge she developed clinical services in these areas including an endocrine-genetics clinic and endocrine tumours service. She is currently focusing on late effects and transition services, as well as focussing patient safety, in particular during the Covid-19 pandemic. She is part of the UCLH Epic Expert Community, working to implement a single electronic patient record, and is an advocate of patient portals so patients can be empowered.  She was recently appointed Clinical Lead for Transformation at UCLH, the aim to make our out-patient services fit for the new world we live in. She is an active member of the Society for Endocrinology, being part of the SfE BES Program Organising Committee,  Editor of The Endocrinologist in 2020 and is Co-Lead for the new Endocrine Network-Endocrine Consequences of Living With and Beyond Cancer.  At UCLH she works with the Late effects multidisciplinary team, focusing on endocrinology across all types of cancers and their treatments, including acute issues for in patients. She is involved in setting up pathways such as a new Neuro-oncology MDT. She works closely with the paediatric teams at UCLH and GISH and improving transition pathways.  She is member of the RCP Patient Safety Committee,  working with RCP, SfE and NHSE&I to improve care for all patients with adrenal insufficiency, including   a new Emergency Steroid Card and National Patient Safety Alert, and working at UCLH to operationalise this work, again within the electronic patient record.  She works closely with patients support groups, being a Trustee for the Addison's Disease Self Help Group and leads Twitter chats on adrenal insufficiency as well as (over) sharing cricket news whenever necessary. She is also a founder member with 3 others of the NEW-London Network of Endocrine Women in London and is excited to be supporting others in their career.